Stemson Therapeutics

Geoff Hamilton, CEO

Oct. 11 | 3:30pm | Rentschler ATMP Ballroom 

San Diego, CA


Stemson Therapeutics is a preclinical stage company developing a novel cell therapy to bioengineer de novo hair follicles to treat Alopecia and hair loss. Stemson is the only company pursuing a cell therapy approach to hair loss by leveraging Induced Pluripotent Stem cell technology. The company aims to deliver an unlimited supply of hair follicles to address a large unmet medical need affecting approximately 15% of the global human population. No therapeutic solution available today is capable of stopping hair loss or generating new follicles to replace those that have been lost. Led by a seasoned team of biotech executives, cell therapy developers, bioengineers, and stem cell biologists, the company has raised $23M through a Series A funding.

By using this website you agree to accept our Privacy Policy and Terms & Conditions